CITADEL ADVISORS LLC

Position in CPHI — China Pharma Holdings, Inc.

CIK 1423053 MIAMI, FL

Position in CPHI

as of Jun 30, 2026 · filed Sep 2, 2026 Compact

Position Value

$82,793

+$74,910 QoQ

Shares Held

125,445

+870.6% QoQ

Ownership

0.292%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 8 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $1,255,675,824 across 65 Drug Manufacturers - Specialty & Generic names. CPHI ranks #53 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc	9,668,611	$237,944,516
2	ZTS	Zoetis Inc.	3,188,263	$229,108,578
3	UTHR	UNITED THERAPEUTICS Corp	304,692	$165,091,266
4	LNTH	Lantheus Holdings, Inc.	1,376,480	$152,706,691
5	INDV	Indivior Pharmaceuticals, Inc.	2,667,827	$109,460,941
6	ALKS	Alkermes plc.	1,645,101	$86,203,291
7	SUPN	Supernus Pharmaceuticals, Inc.	1,373,982	$63,903,902
8	HIMS	Hims & Hers Health, Inc.	846,936	$29,363,271

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$82,793	125,445	+870.6%	Shares	Defined	2026-09-02
2026-03-31	$7,883	12,924	-57.5%	Shares	Defined	2026-05-15
2025-09-30	$59,330	30,426	+31.9%	Shares	Defined	2025-11-14
2025-06-30	$41,295	23,070	-56.5%	Shares	Defined	2025-08-14
2025-03-31	$13,794	53,056	-43.7%	Shares	Defined	2025-05-15
2024-03-31	$34,889	94,296	-43.3%	Shares	Defined	2024-05-15
2023-12-31	$19,945	166,213	+376.9%	Shares	Defined	2024-02-14
2022-06-30	$7,319	34,854	-24.3%	Shares	Defined	2022-08-15
2021-06-30	$33,141	46,030	-65.7%	Shares	Defined	2021-08-16
2021-03-31	$112,775	134,256	+1015.5%	Shares	Defined	2021-05-21
2020-12-31	$5,415	12,035	-87.8%	Shares	Defined	2021-02-16
2020-09-30	$35,470	98,530	+352.5%	Shares	Defined	2020-11-16
2020-03-31	$10,888	21,776	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.